Comparative analysis of cytokine profiles in autoinflammatory and autoimmune conditions

Cytokine

Volumn 50, Issue 2, 2010, Pages 146-151

  Manukyan, Gayane ^a   Ghazaryan, Karine ^a   Ktsoyan, Zhanna ^a   Khachatryan, Zaruhi ^a   Kelly, Denise ^c   Tatyan, Marieta ^a   Agababova, Marina ^b   Aminov, Rustam ^c  

^a INSTITUTE OF MOLECULAR BIOLOGY   (Armenia)

^b Institute of Cardiology   (Armenia)

^c ROWETT RESEARCH INSTITUTE   (United Kingdom)

Author keywords

Cytokines; Discriminant function analysis; ELISA; Familial Mediterranean fever; Systemic lupus erythematosus

Indexed keywords

BIOLOGICAL MARKER; CYTOKINE;

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; AUTOINFLAMMATORY DISEASE; BLOOD SAMPLING; CHILD; COMPARATIVE STUDY; CONTROLLED STUDY; FAMILIAL MEDITERRANEAN FEVER; FEMALE; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; REMISSION; SCHOOL CHILD; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; AGED; AUTOIMMUNITY; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHILD; CYTOKINES; DISCRIMINANT ANALYSIS; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 77950861385     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2010.02.014     Document Type: Article

References (53)

1. Hawkins P.N., Lachmann H.J., Aganna E., McDermott M.F. Spectrum of clinical features in Muckle-Wells syndrome and response to anakinra. Arthritis Rheum 2004, 50:607-612.
2. Roldan R., Ruiz A.M., Miranda M.D., Collantes E. Anakinra: new therapeutic approach in children with familial Mediterranean fever resistant to colchicine. Joint Bone Spine 2008, 75:504-505.
3. Elliot M.J., Maini R.N., Feldmann M., Long-Fox A., Charles P., Katasikis P., et al. Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha. Arthritis Rheum 2008, 58:S92-S101.
4. McDermott M.F., Aksentijevich I., Galon J., McDermott E.M., Ogunkolade B.W., Centola M., et al. Germline mutations in the extracellular domains of the 55kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell 1999, 97:133-144.
5. Brydges S., Kastner D.L. The systemic autoinflammatory diseases: inborn errors of the innate immune system. Curr Top Microbiol Immunol 2006, 305:127-160.
6. Masters S.L., Simon A., Aksentijevich I., Kastner D.L. Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease. Annu Rev Immunol 2009, 27:621-668.
7. Stojanov S., Kastner D.L. Familial autoinflammatory diseases: genetics, pathogenesis and treatment. Curr Opin Rheumatol 2005, 17:586-599.
8. The International FMF Consortium. Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell 1997;90:797-07.
9. The French FMF Consortium. A candidate gene for familial Mediterranean fever. Nat Genet 1997;17:25-31.
10. Centola M., Wood G., Frucht D.M., Galon J., Aringer M., Farrell C., et al. The gene for familial Mediterranean fever, MEFV, is expressed in early leukocyte development and is regulated in response to inflammatory mediators. Blood 2000, 95:3223-3231.
11. Dean G.S., Tyrrell-Price J., Crawley E., Isenberg D.A. Cytokines and systemic lupus erythematosus. Ann Rheum Dis 2000, 59:243-251.
12. Via C.S., Handwerger B.S. B-cell and T-cell function in systemic lupus erythematosus. Curr Opin Rheumatol 1993, 5:570-574.
13. Cooper G.S., Dooley M.A., Treadwell E.L., St.Clair E.W., Parks C.G., Gilkeson G.S. Hormonal, environmental, and infectious risk factors for developing systemic lupus erythematosus. Arthritis Rheum 1998, 41:1714-1724.
14. Kanta H., Mohan C. Three checkpoints in lupus development: central tolerance in adaptive immunity, peripheral amplification by innate immunity and end-organ inflammation. Genes Immun 2009, 10:390-396.
15. McGonagle D., McDermott M.F. A proposed classification of the immunological diseases. PLoS Med 2006, 3:e297.
16. Capper E.R., Maskill J.K., Gordon C., Blakemore A.I. Interleukin (IL)-10, IL-1ra and IL-12 profiles in active and quiescent systemic lupus erythematosus: could longitudinal studies reveal patient subgroups of differing pathology?. Clin Exp Immunol 2004, 138:348-356.
17. Chun H.Y., Chung J.W., Kim H.A., Yun J.M., Jeon J.Y., Ye Y.M., et al. Cytokine IL-6 and IL-10 as biomarkers in systemic lupus erythematosus. J Clin Immunol 2007, 27:461-466.
18. Manukyan G.P., Ghazaryan K.A., Ktsoyan Zh.A., Tatyan M.V., Khachatryan Z.A., Hakobyan G.S., et al. Cytokine profile of Armenian patients with familial Mediterranean fever. Clin Biochem 2008, 41:920-922.
19. Musabak U., Sengul A., Oktenli C., Pay S., Yesilova Z., Kenar L., et al. Does immune activation continue during an attack-free period in familial Mediterranean fever?. Clin Exp Immunol 2004, 138:526-533.
20. Simon A., van der Meer J.W. Pathogenesis of familial periodic fever syndromes or hereditary autoinflammatory syndromes. Am J Physiol Regul Integr Comp Physiol 2007, 292:R86-R98.
21. Chae J.J., Wood G., Masters S.L., Richard K., Park G., Smith B.J., et al. The B30.2 domain of pyrin, the familial Mediterranean fever protein, interacts directly with caspase-1 to modulate IL-1beta production. Proc Natl Acad Sci USA 2006, 103:9982-9987.
22. Yu J.W., Wu J., Zhang Z., Datta P., Ibrahimi I., Taniguchi S., et al. Cryopyrin and pyrin activate caspase-1, but not NF-kappaB, via ASC oligomerization. Cell Death Differ 2006, 13:236-249.
23. Fairhurst A.M., Wandstrat A.E., Wakeland E.K. Systemic lupus erythematosus: multiple immunological phenotypes in a complex genetic disease. Adv Immunol 2006, 92:1-69.
24. Livneh A., Langevitz P., Zemer D., Zaks N., Kees S., Lidar T. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 1997, 40:1879-1885.
25. Tan E.M., Cohen A.S., Fries J.F., Masi A.T., McShane D.J., Rothfield N.F., et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982, 25:1271-1277.
26. Hochberg M.C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997, 40:1725.
27. Bombardier C., Gladman D.D., Urowitz M.B., Caron D., Chang C.H. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992, 35:630-640.
28. Dinarello C.A. Setting the cytokine trap for autoimmunity. Nat Med 2003, 9:20-22.
29. Khachatryan Z.A., Ktsoyan Z.A., Manukyan G.P., Kelly D., Ghazaryan K.A., Aminov R.I. Predominant role of host genetics in controlling the composition of gut microbiota. PLoS One 2008, 3:e3064.
30. Manukyan G.P., Ghazaryan K.A., Ktsoyan Z.A., Khachatryan Z.A., Arakelova K.A., Kelly D., et al. Elevated systemic antibodies towards commensal gut microbiota in autoinflammatory condition. PLoS One 2008, 3:e3172.
31. Kitamura K., Nakamoto Y., Kaneko S., Mukaida N. Pivotal roles of interleukin-6 in transmural inflammation in murine T cell transfer colitis. J Leukoc Biol 2004, 76:1111-1117.
32. Tackey E., Lipsky P.E., Illei G.G. Rationale for interleukin-6 blockade in systemic lupus erythematosus. Lupus 2004, 13:339-343.
33. Schindler R., Mancilla J., Endres S., Ghorbani R., Clark S.C., Dinarello C.A. Correlations and interactions in the production of interleukin-6 (IL-6), IL-1 and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF. Blood 1990, 75:40-47.
34. Tilg H., Dinarello C.A., Mier J.W. IL-6 and APPs: anti-inflammatory and immunosuppressive mediators. Immunol Today 1997, 18:428-432.
35. Roncarolo M.G., Bacchetta R., Bordignon C., Narula S., Levings M.K. Type 1 T regulatory cells. Immunol Rev 2001, 182:68-79.
36. Moore K.W., de Waal Malefyt R., Coffman R.L., O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001, 19:683-765.
37. + Tregs: limiting collateral damage. J Clin Invest 2004, 114:1372-1378.
38. Sakaguchi S., Sakaguchi N., Shimizu J., Yamazaki S., Sakihama T., Itoh M., et al. Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol Rev 2001, 182:18-32.
39. Katschke K.J., Rottman J.B., Ruth J.H., Qin S., Wu L., LaRosa G., et al. Differential expression of chemokine receptors on peripheral blood, synovial fluid, and synovial tissue monocytes/macrophages in rheumatoid arthritis. Arthritis Rheum 2001, 44:1022-1032.
40. Hoffman R.W. T cells in the pathogenesis of systemic lupus erythematosus. Front Biosci 2001, 6:D1369-D1378.
41. Lit L.C., Wong C.K., Tam L.S., Li E.K., Lam C.W. Raised plasma concentration and ex vivo production of inflammatory chemokines in patients with systemic lupus erythematosus. Ann Rheum Dis 2006, 65:209-215.
42. Liu T.F., Jones B.M. Impaired production of IL-12 in systemic lupus erythematosus I. Excessive production of IL-10 suppresses production of IL-12 by monocytes. Cytokine 1998, 10:140-147.
43. Tokano Y., Morimoto S., Kaneko H., Amano H., Nozawa K., Takasaki Y., et al. Levels of IL-12 in the sera of patients with systemic lupus erythematosus (SLE) - relation to Th1 and Th2 derived cytokines. Clin Exp Immunol 1999, 116:169-173.
44. Gröndal G., Gunnarsson I., Rönnelid J., Rogberg S., Klareskog L., Lundberg I. Cytokine production, serum levels and disease activity in systemic lupus erythematosus. Clin Exp Rheumatol 2000, 18:565-570.
45. Viallard J.F., Pellegrin J.L., Ranchin V., Schaeverbeke T., Dehais J., Longy-Boursier M., et al. Th1 (IL-2, interferon-gamma (IFN-gamma)) and Th2 (IL-10, IL-4) cytokine production by peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE). Clin Exp Immunol 1999, 115:189-195.
46. Simsek I., Pay S., Pekel A., Dinc A., Musabak U., Erdem H., et al. Serum proinflammatory cytokines directing T helper 1 polarization in patients with familial Mediterranean fever. Rheumatol Int 2007, 27:807-811.
47. Wong C.K., Lit L.C., Tam L.S., Li E.K., Wong P.T., Lam C.W. Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in auto-immunity. Clin Immunol 2008, 127:385-393.
48. Afzali B., Lombardi G., Lechler I., Lord G.M. The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease. Clin Exp Immunol 2007, 148:32-46.
49. Happel K.I., Dubin P.J., Zheng M., Ghilardi N., Lockhart C., Quinton L.J., et al. Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae. J Exp Med 2005, 202:761-769.
50. Chen Z., Tato C.M., Muul L., Laurence A., O'Shea J.J. Distinct regulation of interleukin-17 in human T helper lymphocytes. Arthritis Rheum 2007, 56:2936-2946.
51. Witowski J., Pawlaczyk K., Breborowicz A., Scheuren A., Kuzlan-Pawlaczyk M., Wisniewska J., et al. IL-17 stimulates intraperitoneal neutrophil infiltration through the release of GRO alpha chemokine from mesothelial cells. J Immunol 2000, 165:5814-5821.
52. Miyamoto M., Prause O., Sjostrand M., Laan M., Lotvall J., Linden A. Endogenous IL-17 as a mediator of neutrophil recruitment caused by endotoxin exposure in mouse airways. J Immunol 2003, 170:4665-4672.
53. Prause O., Laan M., Lotvall J., Linden A. Pharmacological modulation of interleukin-17-induced GCP-2-, GRO-alpha- and interleukin-8 release in human bronchial epithelial cells. Eur J Pharmacol 2003, 462:193-198.